{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T12:42:03Z","timestamp":1726317723624},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-2320-B-002-011"],"award-info":[{"award-number":["MOST 104-2320-B-002-011"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cephamycin-associated hemorrhages have been reported since their launch. This research aimed to determine risk factors for cephamycin-associated hemorrhagic events and produce a risk scoring system using National Taiwan University Hospital (NTUH) database. Patients who were older than 20 years old and consecutively used study antibiotics for more than 48\u2009hours\u00a0(epidode) at NTUH between January 1<jats:sup>st<\/jats:sup>, 2009 and December 31<jats:sup>st<\/jats:sup>, 2015 were included. The population was divided into two cohorts for evaluation of risk factors and validation of the scoring system. Multivariate logistic regression was used for the assessment of the adjusted association between factors and the outcome of interest. Results of the multivariate logistic regression were treated as the foundation to develop the risk scoring system. There were 46402 and 22681 episodes identified in 2009\u20132013 and 2014\u20132015 cohorts with 356 and 204 hemorrhagic events among respective cohorts. Use of cephamycins was associated with a higher risk for hemorrhagic outcomes (aOR 2.03, 95% CI 1.60\u20132.58). Other risk factors included chronic hepatic disease, at least 65 years old, prominent bleeding tendency, and bleeding history. A nine-score risk scoring system (AUROC\u2009=\u20090.8035, 95% CI 0.7794\u20130.8275; Hosmer-Lemeshow goodness-of-fit test <jats:italic>p<\/jats:italic>\u2009=\u20090.1044) was developed based on the identified risk factors, with higher scores indicating higher risk for bleeding. Use of cephamycins was associated with more hemorrhagic events compared with commonly used penicillins and cephalosporins. The established scoring system, CHABB, may help pharmacists identify high-risk patients and provide recommendations according to the predictive risk, and eventually enhance the overall quality of care.<\/jats:p>","DOI":"10.1038\/s41598-019-49340-5","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T10:03:02Z","timestamp":1568023382000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development and Validation of a Risk Scoring System for Cephamycin-Associated Hemorrhagic Events"],"prefix":"10.1038","volume":"9","author":[{"given":"Tong-Ling","family":"Chien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-Yuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Wen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"key":"49340_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1770-1","volume":"16","author":"T Fukuchi","year":"2016","unstructured":"Fukuchi, T., Iwata, K., Kobayashi, S., Nakamura, T. & Ohji, G. Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems. BMC Infect. Dis. 16, 427 (2016).","journal-title":"BMC Infect. Dis."},{"key":"49340_CR2","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/jac\/dkl381","volume":"58","author":"CH Lee","year":"2006","unstructured":"Lee, C. H., Su, L. H., Tang, Y. F. & Liu, J. W. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates. J. Antimicrob. Chemother. 58, 1074\u20131077 (2006).","journal-title":"J. Antimicrob. Chemother."},{"key":"49340_CR3","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/infdis\/158.6.1405","volume":"158","author":"RV McCloskey","year":"1988","unstructured":"McCloskey, R. V. Spontaneous reports of bleeding: comparison of N-methylthiotetrazole side chain (MTT) and non-MTT cephalosporins. J. Infect. Dis. 158, 1405 (1988).","journal-title":"J. Infect. Dis."},{"key":"49340_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/archsurg.1991.01410280128021","volume":"126","author":"CW Kaiser","year":"1991","unstructured":"Kaiser, C. W., McAuliffe, J. D., Barth, R. J. & Lynch, J. A. Hypoprothrombinemia and hemorrhage in a surgical patient treated with cefotetan. Arch. Surg. 126, 524\u2013525 (1991).","journal-title":"Arch. Surg."},{"key":"49340_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/archinte.1986.00360180117019","volume":"146","author":"JS Bertino","year":"1986","unstructured":"Bertino, J. S., Kozak, A. J., Reese, R. E. & Chiarello, L. A. Hypoprothrombinemia associated with cefamandole use in a rural teaching hospital. Arch. Intern. Med. 146, 1125\u20131128 (1986).","journal-title":"Arch. Intern. Med."},{"key":"49340_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ajh.20449","volume":"81","author":"RSM Wong","year":"2006","unstructured":"Wong, R. S. M., Cheng, G., Chan, N. P. H., Wong, W. S. & Ng, M. H. L. Use of cefoperazone still needs a caution for bleeding from induced vitamin K deficiency. Am. J. Hematol. 81, 76\u201376 (2006).","journal-title":"Am. J. Hematol."},{"key":"49340_CR7","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/00007611-198711000-00007","volume":"80","author":"RJ Mueller","year":"1987","unstructured":"Mueller, R. J., Green, D. & Phair, J. P. Hypoprothrombinemia associated with cefoperazone therapy. South. Med. J. 80, 1360\u20131362 (1987).","journal-title":"South. Med. J."},{"key":"49340_CR8","first-page":"96","volume":"201","author":"JG Baxter","year":"1985","unstructured":"Baxter, J. G. et al. Clinical risk factors for prolonged PT\/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin. Ann. Surg. 201, 96\u2013102 (1985).","journal-title":"Ann. Surg."},{"key":"49340_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(80)90571-1","volume":"1","author":"CA Hooper","year":"1980","unstructured":"Hooper, C. A., Haney, B. B. & Stone, H. H. Gastrointestinal-bleeding due to vitamin-K deficiency in patients on parenteral cefamandole. Lancet 1, 39\u201340 (1980).","journal-title":"Lancet"},{"key":"49340_CR10","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1001\/archinte.1986.00360230079013","volume":"146","author":"RB Brown","year":"1986","unstructured":"Brown, R. B. et al. Enhanced bleeding with cefoxitin or moxalactam - statistical-analysis within a defined population of 1493 patients. Arch. Intern. Med. 146, 2159\u20132164 (1986).","journal-title":"Arch. Intern. Med."},{"key":"49340_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/jama.1982.03330090070035","volume":"248","author":"RL Pakter","year":"1982","unstructured":"Pakter, R. L., Russell, T. R., Mielke, C. H. & West, D. Coagulopathy associated with the use of moxalactam. JAMA 248, 1100\u20131100 (1982).","journal-title":"JAMA"},{"key":"49340_CR12","doi-asserted-by":"publisher","first-page":"e0158407","DOI":"10.1371\/journal.pone.0158407","volume":"11","author":"LJ Chen","year":"2016","unstructured":"Chen, L. J. et al. Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study. PLoS One 11, e0158407 (2016).","journal-title":"PLoS One"},{"key":"49340_CR13","unstructured":"Tung, M.-L. Use of Cephamycins and the Risk of Hypoprothrombinemia and Hemorrhagic Events: A Hospital-Based Retrospective Cohort Study. Master of Science thesis, National Taiwan University (2015)."},{"key":"49340_CR14","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan, H. et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care 43, 1130\u20131139 (2005).","journal-title":"Med. Care"},{"key":"49340_CR15","unstructured":"Department of Pharmacy, National Taiwan University Hospital (NTUH). Policy and Protocol: Recommendations on the Use of Warfarin by Anticoagulation Clinic of NTUH, approved by NTUH Pharmacy and Therapeutics Committee on April 8th, 2013."},{"key":"49340_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/(SICI)1099-1557(199903\/04)8:2<81::AID-PDS411>3.0.CO;2-G","volume":"8","author":"BL Strom","year":"1999","unstructured":"Strom, B. L., Schinnar, R., Gibson, G. A., Brennan, P. J. & Berlin, J. A. Risk of bleeding and hypoprothrombinaemia associated with NMTT side chain antibiotics: Using cefoperazone as a test case. Pharmacoepidemiol. Drug Saf. 8, 81\u201394 (1999).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"49340_CR17","doi-asserted-by":"crossref","unstructured":"Hosmer, D. W., Lemeshow, J. S. & Sturdivant, R. X. Assessing the Fit of the Model in Applied Logistic Regression Ch. 5, 153\u2013225 (John Wiley & Sons, Inc., 2013).","DOI":"10.1002\/9781118548387.ch5"},{"key":"49340_CR18","first-page":"1393","volume":"44","author":"R Mehran","year":"2004","unstructured":"Mehran, R. et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J. Am. Coll. Cardiol. 44, 1393\u20131399 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"49340_CR19","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H. & Francis, C. W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111, 4902\u20134907 (2008).","journal-title":"Blood"},{"key":"49340_CR20","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2337\/dc11-0331","volume":"34","author":"BA Lipsky","year":"2011","unstructured":"Lipsky, B. A. et al. Developing and validating a risk score for lower-extremity amputation in patients hospitalized for a diabetic foot infection. Diabetes Care 34, 1695\u20131700 (2011).","journal-title":"Diabetes Care"},{"key":"49340_CR21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1164\/rccm.201305-0863OC","volume":"189","author":"P-C Chan","year":"2014","unstructured":"Chan, P.-C. et al. Risk for tuberculosis in child contacts. Development and validation of a predictive score. Am. J. Respir. Crit. Care Med. 189, 203\u2013213 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"49340_CR22","doi-asserted-by":"publisher","first-page":"e94760","DOI":"10.1371\/journal.pone.0094760","volume":"9","author":"MH Lee","year":"2014","unstructured":"Lee, M. H. et al. Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies. PLoS One 9, e94760 (2014).","journal-title":"PLoS One"},{"key":"49340_CR23","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep.27610","volume":"61","author":"YC Hung","year":"2015","unstructured":"Hung, Y. C. et al. Development of risk scoring system for stratifying population for hepatocellular carcinoma screening. Hepatology 61, 1934\u20131944 (2015).","journal-title":"Hepatology"},{"key":"49340_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5","volume":"19","author":"DG Altman","year":"2000","unstructured":"Altman, D. G. & Royston, P. What do we mean by validating a prognostic model? Stat. Med. 19, 453\u2013473 (2000).","journal-title":"Stat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49340-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49340-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49340-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:21:40Z","timestamp":1671283300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49340-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49340"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49340-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,9]]},"assertion":[{"value":"12 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12905"}}